ENDONOVO THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $28.6K | $-9.3M | $41.5K |
| FY2016 | $3.2M | $-8.6M | $55.5K |
| FY2017 | $7.4M | $-9.6M | $90.2K |
| FY2018 | $8.2M | $-11.4M | $379.2K |
| FY2019 | $6.9M | $-20.5M | $18.9K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $28.6K | $-9.3M | $41.5K |
| FY2016 | $3.2M | $-8.6M | $55.5K |
| FY2017 | $7.4M | $-9.6M | $90.2K |
| FY2018 | $8.2M | $-11.4M | $379.2K |
| FY2019 | $6.9M | $-20.5M | $18.9K |